Intercept Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 2010
Net Income	221.82	-91.43	-274.88	-344.68	-309.24	-360.37	-412.83	-226.43	-283.23	-67.79	Upgrade
Depreciation & Amortization	2.26	7.53	8.21	9.05	4.58	4.6	3.83	1.69	0.44	0.11	Upgrade
Share-Based Compensation	21.89	28.03	49.19	55.98	49.91	56.97	46.21	34.19	20.13	9.45	Upgrade
Other Operating Activities	-272.74	14.8	45.62	43.04	14.03	33.4	20.35	27.65	174.92	30.23	Upgrade
Operating Cash Flow	-26.78	-41.07	-171.86	-236.61	-240.71	-265.4	-342.44	-162.9	-87.74	-28.01	Upgrade
Capital Expenditures	-0.57	-0.4	-3.89	-1.14	-0.17	-10.39	-5.08	-5.94	-4.64	-1.63	Upgrade
Change in Investments	-100.82	71.12	166.71	-187.85	-47.9	298.17	-55.06	-383.54	-91.94	-68.58	Upgrade
Other Investing Activities	363.23	-	-	-	-	-	-	-	-	-0	Upgrade
Investing Cash Flow	261.85	70.73	162.82	-188.99	-48.07	287.78	-60.14	-389.47	-96.59	-70.21	Upgrade
Share Issuance / Repurchase	1.68	-75.81	1.3	236.25	265.73	2.84	5.17	565.47	190.98	66.07	Upgrade
Debt Issued / Paid	-268.44	116.79	0	223.42	0	0	447.57	0	0	0	Upgrade
Other Financing Activities	-0.56	-39.87	-1.99	-2.16	-2.18	-	-38.36	-	-	0	Upgrade
Financing Cash Flow	-267.32	1.12	-0.69	457.52	263.55	2.84	414.38	565.47	190.98	66.07	Upgrade
Exchange Rate Effect	-6.3	-2.02	0.61	-0.39	-1.53	1.13	-0.87	-0.38	0	0	Upgrade
Net Cash Flow	-38.55	28.76	-9.13	31.53	-26.77	26.34	10.93	12.72	6.66	-32.15	Upgrade
Free Cash Flow	-27.35	-41.46	-175.76	-237.75	-240.88	-275.79	-347.52	-168.84	-92.38	-29.64	Upgrade
Free Cash Flow Margin	-9.57%	-15.90%	-75.12%	-94.34%	-133.97%	-210.60%	-1392.81%	-6068.91%	-5303.16%	-1827.07%	Upgrade
Free Cash Flow Per Share	-0.81	-1.30	-5.33	-7.51	-8.46	-11.01	-14.09	-7.13	-4.45	-1.64	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).